Clinical Trial Update: Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days [Phase 1]

View source ↗

Summary

Phase 1 trial update showing safety and tolerability of twice-daily intra-anal NRL001 Cream for 14 days in people with faecal incontinence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Faecal Incontinence

Drugs mentioned

• NRL001 Cream

Snippet

Sponsor: Norgine | Conditions: Faecal Incontinence | Phase 1 | Status: COMPLETED